Medical Journals Serve as Big Pharma Drug-Marketing Platform: Study

The value of medical journals in providing physicians, researchers and other medical professionals an honest glimpse of the latest relevant, peer-reviewed medical science has greatly diminished in recent years. An extensive review published in the journal PLOS Medicine shows that medical journals today serve as little more than marketing platforms for pharmaceutical companies to push their drugs with little in the r the way of unbiased science.

Richard Smith, who served as an editor of the prestigious British Medical Journal (BMJ) for 25 years before resigning in 2004, warns that a bulk of the studies published in medical journals are pioneered by drug companies. More often than not, these studies push the agenda of the companies that launched them, procuring positive results that were cunningly derived through industry sleight of hand.

For the full story read Global Research and PLOS Medicine